Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lewewoo
    Member
    • Apr 2011
    • 60

    #1

    Cufflinks FPKM inconsistent with reads in IGV

    I have 6 samples the FPKM is as following:
    0 0 0.23 0.15 0.56 0.3

    however, when I used IGV to double checked the reads mapped, there are a lot of reads and the amounts mapped in the loci are pretty same; the total reads are not very different.

    Any suggestions?
  • Dario1984
    Senior Member
    • Jun 2011
    • 166

    #2
    All those FPKMs are very low. Do you have any better examples ? I've seen this before in my data.

    The FPKM estimates make no sense. For one, the second transcript from the top has no reads spanning the last intron. I scrolled all the way to the bottom. But it has a FPKM of 53.

    I'm also not sure why the bottom-most transcript has a FPKM of 272. There are very few reads in the exonic part that is unique to it.

    In summary, you don't want to trust Cufflinks estimates. They make no sense. Have you tried NEUMA instead ?

    Comment

    • hugq
      Junior Member
      • Feb 2010
      • 1

      #3
      I found NEUMA work great and the results do make sense at many genes mannually checked.

      Originally posted by Dario1984 View Post
      All those FPKMs are very low. Do you have any better examples ? I've seen this before in my data.

      The FPKM estimates make no sense. For one, the second transcript from the top has no reads spanning the last intron. I scrolled all the way to the bottom. But it has a FPKM of 53.

      I'm also not sure why the bottom-most transcript has a FPKM of 272. There are very few reads in the exonic part that is unique to it.

      In summary, you don't want to trust Cufflinks estimates. They make no sense. Have you tried NEUMA instead ?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...